Free Trial

Induction Healthcare Group (INHC) Competitors

Induction Healthcare Group logo
GBX 10 +0.50 (+5.26%)
As of 09:50 AM Eastern

INHC vs. RENX, COG, FDBK, TRLS, IQAI, DVRG, SENS, EMIS, CRW, and INS

Should you be buying Induction Healthcare Group stock or one of its competitors? The main competitors of Induction Healthcare Group include Renalytix (RENX), Cambridge Cognition (COG), Feedback (FDBK), Trellus Health (TRLS), IQ-AI (IQAI), DeepVerge (DVRG), Sensyne Health (SENS), EMIS Group (EMIS), Craneware (CRW), and Instem (INS). These companies are all part of the "health information services" industry.

Induction Healthcare Group vs.

Induction Healthcare Group (LON:INHC) and Renalytix (LON:RENX) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, profitability, analyst recommendations, community ranking, risk, dividends, earnings and valuation.

Induction Healthcare Group has higher revenue and earnings than Renalytix. Induction Healthcare Group is trading at a lower price-to-earnings ratio than Renalytix, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Induction Healthcare Group£12.57M0.73-£5.12M-£5.54-1.80
Renalytix£9.22M3.66-£109.93M-£21.19-0.38

Induction Healthcare Group has a beta of -0.41, indicating that its share price is 141% less volatile than the S&P 500. Comparatively, Renalytix has a beta of 2.1, indicating that its share price is 110% more volatile than the S&P 500.

46.3% of Induction Healthcare Group shares are held by institutional investors. Comparatively, 28.4% of Renalytix shares are held by institutional investors. 54.6% of Induction Healthcare Group shares are held by company insiders. Comparatively, 35.7% of Renalytix shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Renalytix received 9 more outperform votes than Induction Healthcare Group when rated by MarketBeat users. However, 93.33% of users gave Induction Healthcare Group an outperform vote while only 74.19% of users gave Renalytix an outperform vote.

CompanyUnderperformOutperform
Induction Healthcare GroupOutperform Votes
14
93.33%
Underperform Votes
1
6.67%
RenalytixOutperform Votes
23
74.19%
Underperform Votes
8
25.81%

Induction Healthcare Group has a net margin of -40.70% compared to Renalytix's net margin of -1,191.75%. Renalytix's return on equity of 293.20% beat Induction Healthcare Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Induction Healthcare Group-40.70% -26.97% -7.32%
Renalytix -1,191.75%293.20%-93.54%

In the previous week, Induction Healthcare Group's average media sentiment score of 0.00 equaled Renalytix'saverage media sentiment score.

Company Overall Sentiment
Induction Healthcare Group Neutral
Renalytix Neutral

Summary

Induction Healthcare Group beats Renalytix on 8 of the 13 factors compared between the two stocks.

Get Induction Healthcare Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for INHC and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

INHC vs. The Competition

MetricInduction Healthcare GroupHealth Information Services IndustryMedical SectorLON Exchange
Market Cap£9.23M£211.57M£5.33B£2.66B
Dividend YieldN/A6.68%5.21%5.05%
P/E Ratio-1.80328.9326.85129.21
Price / Sales0.73432.39388.74221,406.02
Price / Cash2.6847.1438.2528.02
Price / Book0.525.356.763.79
Net Income-£5.12M-£15.55M£3.23B£5.88B
7 Day Performance7.86%0.45%1.71%0.63%
1 Month Performance11.11%7.42%11.16%22.11%
1 Year Performance-20.00%6.24%17.17%120.87%

Induction Healthcare Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
INHC
Induction Healthcare Group
N/AGBX 10
+5.3%
N/A-23.2%£9.23M£12.57M-1.8074
RENX
Renalytix
N/AGBX 8.01
-2.9%
N/A-62.8%£33.20M£9.22M-0.38102
COG
Cambridge Cognition
N/AGBX 38
+1.3%
N/A-14.2%£15.91M£15.64M-10.1080
FDBK
Feedback
N/AGBX 13.55
-1.5%
N/A-80.6%£5.94M£3.88M-0.5524
TRLS
Trellus Health
N/AGBX 1.73
-6.5%
N/A+24.6%£3.34M£65,831.01-0.5031Gap Down
IQAI
IQ-AI
N/AGBX 0.83
+1.0%
N/A-39.3%£1.85M£538,190.00-13.676News Coverage
DVRG
DeepVerge
N/AN/AN/AN/A£1.14M£12.41M-15.0073
SENS
Sensyne Health
N/AN/AN/AN/A£583,000.00£7.81M-0.0270Gap Down
EMIS
EMIS Group
N/AN/AN/AN/A£1.23B£176.86M4,085.111,560News Coverage
CRW
Craneware
2.5875 of 5 stars
GBX 2,050
+4.1%
GBX 2,800
+36.6%
-2.7%£880.82M£230.77M75.74734Gap Down
INS
Instem
N/AN/AN/AN/A£199.62M£61.63M5,928.57500Positive News

Related Companies and Tools


This page (LON:INHC) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners